(1) Summary of Significant Accounting Policies (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Cash And Cash Equivalents Fair Value	$ 12,610,504		$ 12,610,504		$ 4,285,309
Restricted cash	750,000		750,000		750,000
Marketable Securities Fair Value	5,764,839		5,764,839		10,530,942
Depreciation Expense	570,711	631,009	1,719,139	2,137,809
Amortization Expense	34,108	30,175	91,337	88,424
Patents amortized over three years	P3Y	P3Y	P3Y	P3Y
Capitalized Software Development Costs	582,872	0	830,301	461,555
Capitalized Computer Software Amortization	82,063	82,063	246,188	219,201
Foreign Currency Transaction Gain (Loss)	(100,000)	100,000	(900,000)	(200,000)
Common stock equivalents excluded from diluted net loss per share	18,119,241	12,611,396	18,119,241	12,611,396
Cost method investments	900,000		900,000		900,000
Equity Transfer Agreement for possible sale of Blue Whale	$ 3,000,000
Stock option and restricted stock Awards
Common stock equivalents excluded from diluted net loss per share	9,337,725	12,611,396	9,337,725	12,611,396
Redeemable convertible preferred stock
Common stock equivalents excluded from diluted net loss per share	8,781,516		8,781,516
Minimum
Estimated useful lives of the assets			3 years	3 years
Maximum
Estimated useful lives of the assets			7 years	7 years